Jasper Therapeutics, Inc. · NASDAQ:JSPR
Soleus Capital Management, L.P.'s stake in Jasper Therapeutics, Inc. fell to 1.00% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 8, 2026
Soleus Capital Management, L.P.'s stake in Jasper Therapeutics, Inc. fell to 1.00%, 276,312 shares, as a passive investor on Mar 31, 2026. Filed May 8, 2026 (Schedule 13G/A).
- Stake
- 1.00%
- Shares
- 276,312
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Capital Master Fund, L.P. | 0.40% | 118,912 |
| Soleus Private Equity Fund III, L.P. | 0.60% | 157,400 |
| Soleus Private Equity GP III, LLC | 0.60% | 157,400 |
| Soleus PE GP III, LLC | 0.60% | 157,400 |
| Soleus Capital, LLC | 0.40% | 118,912 |
| Soleus Capital Group, LLC | 0.40% | 118,912 |
| Soleus Capital Management, L.P. | 1.00% | 276,312 |
| Soleus GP, LLC | 1.00% | 276,312 |
| Guy Levy | 1.00% | 276,312 |
Source
Related
- Jasper Therapeutics, Inc.
- Soleus Capital Master Fund, L.P.
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Feb 11, 2025
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026